Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AD26.COV2.S: 433 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
433
Total FAERS Reports
17 (3.9%)
Deaths Reported
115
Hospitalizations
433
As Primary/Secondary Suspect
9
Life-Threatening
3
Disabilities

First Report: 20160101 · Latest Report: 20241106

What Are the Most Common AD26.COV2.S Side Effects?

#1 Most Reported
Covid-19
58 reports (13.4%)
#2 Most Reported
Fatigue
47 reports (10.9%)
#3 Most Reported
Off label use
43 reports (9.9%)

All AD26.COV2.S Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Covid-19 58 13.4% 0 18
Fatigue 47 10.9% 0 12
Off label use 43 9.9% 0 13
Headache 42 9.7% 0 6
Pain 41 9.5% 0 18
Pyrexia 40 9.2% 0 11
Malaise 38 8.8% 0 12
Arthralgia 32 7.4% 0 11
Chills 31 7.2% 0 8
Nausea 25 5.8% 0 9
Pain in extremity 24 5.5% 1 5
Covid-19 immunisation 22 5.1% 0 6
Diarrhoea 21 4.9% 0 8
Drug ineffective 20 4.6% 0 4
Feeling abnormal 20 4.6% 0 3
Vaccination failure 20 4.6% 0 2
Illness 19 4.4% 0 5
Rash 19 4.4% 0 1
Suspected covid-19 18 4.2% 0 2
Myalgia 17 3.9% 0 5

Who Reports AD26.COV2.S Side Effects? Age & Gender Data

Gender: 65.7% female, 34.3% male. Average age: 53.3 years. Most reports from: US. View detailed demographics →

Is AD26.COV2.S Getting Safer? Reports by Year

YearReportsDeathsHosp.
2016 1 0 1
2017 3 0 3
2018 1 0 1
2019 9 0 2
2020 17 0 5
2021 187 13 62
2022 56 0 15
2023 14 0 8
2024 3 0 0

View full timeline →

What Is AD26.COV2.S Used For?

IndicationReports
Covid-19 immunisation 190
Immunisation 113
Covid-19 prophylaxis 64
Product used for unknown indication 37

AD26.COV2.S vs Alternatives: Which Is Safer?

AD26.COV2.S vs ADAGRASIB AD26.COV2.S vs ADALIMUMAB AD26.COV2.S vs ADALIMUMAB-AACF AD26.COV2.S vs ADALIMUMAB-AATY AD26.COV2.S vs ADALIMUMAB-ADAZ AD26.COV2.S vs ADALIMUMAB-ADBM AD26.COV2.S vs ADALIMUMAB-AFZB AD26.COV2.S vs ADALIMUMAB-ATTO AD26.COV2.S vs ADALIMUMAB-BWWD AD26.COV2.S vs ADALIMUMAB-FKJP

Official FDA Label for AD26.COV2.S

Official prescribing information from the FDA-approved drug label.